FDA panel backs Schering-Plough cancer drug
Monday, October 5, 2009 - 11:56
in Health & Medicine
(AP) -- Federal health advisers voted 6-4 on Monday that the potential benefits of a Schering-Plough drug outweigh its toxic risks as a treatment for late-stage skin cancer.